Markets

  • Today's Top Stories
  • Commentary and Analysis
  • Press Release
  • Market Update
15 Search Results for: amd
Back to Today's Top Stories
AMD Shares Move Higher, Intel Shares Move Lower After Traders Circulate Report Titled 'Intel has another delay to a major server platform'
8:58AM ET 7/10/2020 Benzinga

A Dell EMC PowerEdge R6525 Handled More Transactions Per Minute and Provided Better Performance Per Dollar Than an HPE ProLiant DL360 Gen10, New Study Finds
3:00AM ET 7/10/2020 PR.com

Principled Technologies (PT) tested the online transaction processing (OLTP) capabilities and compared the price-to-performance ratio of a Dell EMC PowerEdge R6525 with AMD EPYC 7F72 processors to...

Eye Health Supplements Market Demand 2020| Key Findings, Regional Analysis, Covid19 Impact, Key Players Profiles and Future Prospects
4:05PM ET 7/08/2020 AB Digital, Inc.

LumiThera Closes Series C Round of Financing
7:42AM ET 7/08/2020 PRNewswire

SEATTLE, July 8, 2020 /PRNewswire/  LumiThera Inc., a commercial stage private medical device company, creating a multi-wavelength...

DIAWAY presents EDGEBOX™: A complete server solution with perfectly bundled hardware equipment that gives customers the full power of edge computing
8:01AM ET 7/07/2020 PRWeb

To complete the EDGEBOX™ solution, DIAWAY teamed up with AMD, Western Digital, and Juniper Networks to deliver one of the most flexible, high performing, and affordable one-socket edge...

DIAWAY presents EDGEBOX™: A complete server solution with perfectly bundled hardware equipment that gives customers the full power of edge computing
8:00AM ET 7/07/2020 PRNewswire

TALLINN, Estonia, July 7, 2020 /PRNewswire-PRWeb/...

Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases
8:00AM ET 7/07/2020 Business Wire

  • The collaboration with Numab Therapeutics expands Boehringer Ingelheim's bi- and multi-specific antibody pipeline with two front-runner projects in lung and...

Apellis Completes Enrollment In Two Phase 3 Studies Of Targeted C3 Therapy, Pegcetacoplan, In Patients With Geographic Atrophy
7:04AM ET 7/07/2020 Benzinga

  • Pivotal Phase 3 DERBY and OAKS studies enrolled a total of 1,259 patients
     
  • Top-line results expected...

Another New High For Semis
4:29AM ET 7/07/2020 
VisionCare, Inc. Names Thomas Ruggia as New Chief Executive Officer
11:00AM ET 7/06/2020 Business Wire

VisionCare, Inc. ("VisionCare"), a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), today announced that Thomas Ruggia has been...